UnitedHealth Drug Evidence “Hierarchy” Demands Observational Data Be Peer-Reviewed
Executive Summary
During a March 12 symposium, UnitedHealth executive Lewis Sandy discusses evidence requirements for drug outcomes, employers’ interest in reference pricing for drugs and concerns with variations in specialty drug costs based on site of care.